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Introduction
Introduction: chronic rheumatic diseases affect around
2000 children in the Ile-de-France region. Most patients
suffer from juvenile idiopathic arthritis (JIA) that leads to
chronic pain, fatigue and structural damage responsible
for short- and long-term disability. Several physicians and
health professionals may be involved in the treatment and
care of these patients. This multidisciplinary approach is
particularly important in managing paediatric rheumatic
diseases, since many symptoms are chronic and change in
severity over time. The RESRIP (Réseau pour les
Rhumatismes Inflammatoires Pédiatriques) network has
been created to improve and personalize patient care
coordination.
Objectives
Objectives: improvement of patients care in a non-hospital
setting, development of therapeutic education at home in
order to ameliorate treatment adherence; supporting the
transition period from paediatric to adult health care;
reduction of costs thanks to lower need for hospitalization
and medical transportation.
Methods
Patients and methods: any patient aged equal or less
than 18 years suffering from chronic inflammatory dis-
eases having given informed consent could be enrolled
in the network. Patients needed to meet at least two of
the following criteria: disease complexity (impact on:
physical or psychological status, school attendance,
growth and/or development; complexity of treatment);
association of two or more diseases; necessity of at least
3 different health professionals; social difficulties;
demand of support expressed by the patient or the
parents; transition to adult health care; patient fol-
lowed in a peripheral hospital. Physician network coor-
dinator evaluates patient needs, establishes care
process and weaves relationships between the different
health professionals. A patient notebook helps this
process. Health professionals enter into the network
after signing the specific informed consent too.
Patients and health professionals inclusions started in
September 2013.
Results
Results: at present 46 patients (29F, 17M, median age
10,8 years, median disease duration 3,1 years) have been
included. Principal diseases were: JIA (32 patients:
polyarticular 14, oligoarticular 10, psoriatic arthritis 3,
enthesitis-related arthritis 3, systemic 2); connective tis-
sue diseases (6), auto-inflammatory diseases 4, idiopathic
uveitis 2, other 2. Seventy-five health professionals have
adhered to the network.
Conclusion
Conclusion: RESRIP is the first French network dedicated
to children and adolescents with chronic rheumatic dis-
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